Skip navigation
Agenda

Innovative Pharmacy and Distribution Models Driven by Market Dynamics, Product Type, Site of Care and Reimbursement

December 3-5, 2019
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, DECEMBER 3, 2019

1:00

Conference Registration

2:00

CHOOSE BETWEEN TWO SUMMITS (I-II)

I. New Product Launch Planning

Marc Duey
Chief Innovation Officer
Concerto HealthAI

Paul Chen
Senior Director,
Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

Spencer Miller
Senior Director,
Trade & Channel Development
Romark

II. Mitigate Compliance Risk in Manufacturer and Specialty Pharmacy Contracts

Shannon Wiley
Attorney
Bass Berry & Sims PLC

3:30

Networking and Refreshment Break

4:00

CHOOSE BETWEEN TWO SUMMITS (III-IV)

III. Digital and Blockchain Technology Adoption and Implementation

John Bass
Founder and CEO
Hashed Health

IV. Retail and Point-of-Sale Contracting

Jonathan Ogurchak, PharmD, CSP
Adjunct Professor, Master of Science in Pharmacy Business Administration
University of Pittsburgh

5:30

Close of Day One

Join Us... 15TH ANNIVERSARY CELEBRATION immediately following the summits on day one

DAY TWO WEDNESDAY, DECEMBER 4, 2019

7:30

Continental Breakfast Hosted by: Shields Health Solutions logo

8:30

Chairperson’s Welcome and Opening Remarks

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

8:45

HIGHLY-ACCLAIMED OPENING KEYNOTE Drug Channels Update — Things to Watch in 2020

Adam J. Fein, PhD
CEO
Drug Channels Institute

9:30

WALL STREET INSIGHTS Examine Revolutionary Deals, Market Dynamics and e-Commerce Players Impacting the Life Sciences Sector

MODERATOR:

Adam J. Fein, PhD
CEO
Drug Channels Institute

PANELISTS:

Bob Jones
Managing Director
Goldman Sachs

George Hill
Managing Director, Equity Research Analyst
Deutsche Bank Securities

Eric Coldwell
Managing Director, Senior Equity Research Analyst
Robert W. Baird & Co.

10:15

Networking and Refreshment Break

10:45

STATE OF PLAY Trends in Logistics, Distribution and Pharmacy for Orphan, Rare, Cell, Gene and Regenerative Therapies

I. 3PL Trends

II. Distribution Snapshot

III. Pharmacy Models

William Roth
Founding Partner
Blue Fin Group

11:30

Specialty Pharmacy Spotlight —
Deep Dive on Economics, Viability and Innovation

Rich Gourash
Vice President, Specialty Outcomes
Therigy

12:15

Networking Luncheon

1:15

Benefit Design and Network Management — Zero-In on Channel Strategies for Specialty Pharmacy Benefit and Specialty Medical Benefit

Gerard Rivera, PharmD
Chief Executive Officer
Pacific Pharmacy Group

Paul Maurer
Senior Consultant
Protean LLC

2:00

Critical Considerations for Optimizing Access to Rare and Orphan Therapies

Matt Seibt
Chief Commercial Officer
Acer Therapeutics Inc.

2:30

Networking and Refreshment Break

3:00

MEETING OF THE MANUFACTURER MINDS Network Blueprint for Trade and Channel — Strategic and Tactical Approaches Based on Site of Care, Product Type and Reimbursement

Richard Williams, RPh
Senior Vice President, Pharmaceutical Innovation and Insights
CSI Specialty Group

Mike Steelman
Vice President, Market Access
TherapueticsMD

3:45

CASE STUDY Driving Improved Health and Economic Outcomes by Incorporating IDN-SPs in Manufacturer Network Design and Strategy

Stacy Walton, RN, BSN
Vice President, Trade Relations
Shields Health Solutions

Ameet Wattamwars, Pharm. D.
Specialty Pharmacy Program Director
NYU Langone Health System

4:15

The State of Patient Status Visibility and the Use of AI to Drive Specialty Channel Insights

Joshua Halpern
Co-Founder and Executive Vice President, Product and Strategy
IntegriChain

4:45

Brief Transition Break

5:00

CHOOSE FROM THREE WORKSHOPS (A-C)

A. Industry-Only* Trade Director’s Executive Exchange

FACILITATOR:

Mike Steelman
Vice President, Market Access
TherapueticsMD

*CBI reserves the right to qualify participants for this session.

B. Forward-Thinking Strategies for
Specialty Generics and Biosimilars

Richard Williams, RPh
Senior Vice President, Pharmaceutical Innovation and Insights
CSI Specialty Group

C. 340B — Best Practices to
Improve Compliance and Manage Drug Diversion

Tess Morgan
Senior Manager, Product Diversion and Program Integrity
Pfizer Inc

5:45

Close of Day Two

Networking, Wine and
Cheese Reception
immediately following the close of day two

DAY THREE THURSDAY, DECEMBER 5, 2019

7:00

Women’s Leadership Breakfast Forum

This high-touch networking and learning course, tailored to women executives within the life sciences community, illustrates how women are climbing the leadership ladder and redefining career paths and empowerment. Hear compelling stories of personal career success, reflect on professional development opportunities, discover flashpoint moments and ways to inspire and elevate teams. Attendees discover meaningful mentorships and insights into optimal job placement and professional pathways.

7:15

Continental Breakfast

7:50

Chairperson’s Recap

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

LUMINARY SHOWCASE Stay on the Pulse of Industry Innovations and Market Disruptors

8:00

Fireside Chat — Candid Conversation with an Industry Pioneer

William Roth
Founding Partner
Blue Fin Group

Bill Martin
Vice President, General Manager, Chief Commercial Officer
Accredo – An Express Scripts Company

8:45

PARTNERSHIP PAVILION Supply Chain Stakeholders Sound Off — Innovative Models Being Leveraged to Drive Product Pull Through and Patient Access

MODERATOR:

Clint Shadinger, PharmD, MBA
Strategic Clinical Program Manager, Trade Relations
Shields Health Solutions

CONVERSATION CONTRIBUTORS:

Jim Van Lieshout, MBA
Senior Director, Industry Relations and Contracting
Navitus Health Solutions

Ameet Wattamwars, Pharm. D.
Specialty Pharmacy Program Director
NYU Langone Health System

Stephen Samuel
CEO
Premier Pharmacy Services

9:30

How the New Wave of Algorithmic Care Will Disrupt Your Business

Zen Chu
Investor, PillPack;
Senior Lecturer in Healthcare Innovation,
MIT Sloan School of Management and Harvard-MIT Health Sciences & Technology

10:00

HHS KEYNOTE Healthcare Policy Address —
Current State of Regulatory Reform Driving Innovation and Access

Will Brady
Chief of Staff to the Deputy Secretary, Senior Advisor to the Secretary
Department of Health and Human Services (HHS)

10:30

Networking and Refreshment Break

11:00

CHOOSE FROM THREE TAILORED TRACKS (1-3)

1. Specialty Channel Network Design and Contracting

11:00

Creative Contracts —
Cutting-Edge Frameworks Tailored to the Needs of the Market

Donovan Quill
President & CEO
Optime Care Inc.

Tim Silcox
National Director, Trade and Reimbursement
MannKind Corporation

Charles Gayer
Chief Commercial Officer
Biocryst

11:40

Navigate Narrow Networks — Ensuring Patients Don’t Hit Roadblocks

Bob Raffo
President and CEO
FirstView

Tom Doyle
Senior Vice President, Strategy and Commercial Solutions
EVERSANA

Stuart Parker
Senior Director, Trade Relations
Mayne Pharma

12:20

Networking Luncheon

1:20

Assessment of Channel Partners and Determining Who Should Do What —
3PL? Distributor? Pharmacy?

Mark Polidoro
Director, Consulting Services
ValueCentric

2. Market Access, Patient Support and Hub Services Optimization

11:00

Key Considerations for Market Access Compliance

Jennifer Chillas
Senior Corporate Counsel, Law Department
Bristol-Myers Squibb

Michael Diaco
Assistant General Counsel
Pfizer

11:40

Striking the Right Balance —
A Look at the Level of Integration between Hub and Pharmacy

MODERATOR:

Snehal Patel
Vice President, Pharmacy and Access Solutions
Asembia

PANELISTS:

Allison Bridges
Senior Director, Access and Trade
kaléo

Paul Chen
Senior Director, Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

12:20

Networking Luncheon

1:20

Access and Affordability —
Zero-In on Coupons, Copays and Accumulator Programs

Daniel Lozano
Director of Operations
Rx Experts, Inc.

Stephen Hom, PharmD
Executive Vice President
Rx Experts, Inc.

3. Next-Gen Specialty Product Data Strategies

11:00

Optimization of Data Strategy and Alignment with the Business

Stephanie Levin
SBL Data Consulting, LLC

11:40

Getting Launch Ready in Rare Disease — Leveraging Machine Learning on Integrated Cross Channel Claims Data

Nitin Choudhary
Vice President, Consulting
IPM.ai

12:20

Networking Luncheon

2:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, DECEMBER 3, 2019

1:00

Conference Registration

2:00

CHOOSE BETWEEN TWO SUMMITS (I-II)

I. New Product Launch Planning

Marc Duey
Chief Innovation Officer
Concerto HealthAI

Paul Chen
Senior Director,
Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

Spencer Miller
Senior Director,
Trade & Channel Development
Romark

II. Mitigate Compliance Risk in Manufacturer and Specialty Pharmacy Contracts

Shannon Wiley
Attorney
Bass Berry & Sims PLC

3:30

Networking and Refreshment Break

4:00

CHOOSE BETWEEN TWO SUMMITS (III-IV)

III. Digital and Blockchain Technology Adoption and Implementation

John Bass
Founder and CEO
Hashed Health

IV. Retail and Point-of-Sale Contracting

Jonathan Ogurchak, PharmD, CSP
Adjunct Professor, Master of Science in Pharmacy Business Administration
University of Pittsburgh

5:30

Close of Day One

Join Us... 15TH ANNIVERSARY CELEBRATION immediately following the summits on day one

DAY TWO WEDNESDAY, DECEMBER 4, 2019

7:30

Continental Breakfast Hosted by: Shields Health Solutions logo

8:30

Chairperson’s Welcome and Opening Remarks

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

8:45

HIGHLY-ACCLAIMED OPENING KEYNOTE Drug Channels Update — Things to Watch in 2020

Adam J. Fein, PhD
CEO
Drug Channels Institute

9:30

WALL STREET INSIGHTS Examine Revolutionary Deals, Market Dynamics and e-Commerce Players Impacting the Life Sciences Sector

MODERATOR:

Adam J. Fein, PhD
CEO
Drug Channels Institute

PANELISTS:

Bob Jones
Managing Director
Goldman Sachs

George Hill
Managing Director, Equity Research Analyst
Deutsche Bank Securities

Eric Coldwell
Managing Director, Senior Equity Research Analyst
Robert W. Baird & Co.

10:15

Networking and Refreshment Break

10:45

STATE OF PLAY Trends in Logistics, Distribution and Pharmacy for Orphan, Rare, Cell, Gene and Regenerative Therapies

I. 3PL Trends

II. Distribution Snapshot

III. Pharmacy Models

William Roth
Founding Partner
Blue Fin Group

11:30

Specialty Pharmacy Spotlight —
Deep Dive on Economics, Viability and Innovation

Rich Gourash
Vice President, Specialty Outcomes
Therigy

12:15

Networking Luncheon

1:15

Benefit Design and Network Management — Zero-In on Channel Strategies for Specialty Pharmacy Benefit and Specialty Medical Benefit

Gerard Rivera, PharmD
Chief Executive Officer
Pacific Pharmacy Group

Paul Maurer
Senior Consultant
Protean LLC

2:00

Critical Considerations for Optimizing Access to Rare and Orphan Therapies

Matt Seibt
Chief Commercial Officer
Acer Therapeutics Inc.

2:30

Networking and Refreshment Break

3:00

MEETING OF THE MANUFACTURER MINDS Network Blueprint for Trade and Channel — Strategic and Tactical Approaches Based on Site of Care, Product Type and Reimbursement

Richard Williams, RPh
Senior Vice President, Pharmaceutical Innovation and Insights
CSI Specialty Group

Mike Steelman
Vice President, Market Access
TherapueticsMD

3:45

CASE STUDY Driving Improved Health and Economic Outcomes by Incorporating IDN-SPs in Manufacturer Network Design and Strategy

Stacy Walton, RN, BSN
Vice President, Trade Relations
Shields Health Solutions

Ameet Wattamwars, Pharm. D.
Specialty Pharmacy Program Director
NYU Langone Health System

4:15

The State of Patient Status Visibility and the Use of AI to Drive Specialty Channel Insights

Joshua Halpern
Co-Founder and Executive Vice President, Product and Strategy
IntegriChain

4:45

Brief Transition Break

5:00

CHOOSE FROM THREE WORKSHOPS (A-C)

A. Industry-Only* Trade Director’s Executive Exchange

FACILITATOR:

Mike Steelman
Vice President, Market Access
TherapueticsMD

*CBI reserves the right to qualify participants for this session.

B. Forward-Thinking Strategies for
Specialty Generics and Biosimilars

Richard Williams, RPh
Senior Vice President, Pharmaceutical Innovation and Insights
CSI Specialty Group

C. 340B — Best Practices to
Improve Compliance and Manage Drug Diversion

Tess Morgan
Senior Manager, Product Diversion and Program Integrity
Pfizer Inc

5:45

Close of Day Two

Networking, Wine and
Cheese Reception
immediately following the close of day two

DAY THREE THURSDAY, DECEMBER 5, 2019

7:00

Women’s Leadership Breakfast Forum

This high-touch networking and learning course, tailored to women executives within the life sciences community, illustrates how women are climbing the leadership ladder and redefining career paths and empowerment. Hear compelling stories of personal career success, reflect on professional development opportunities, discover flashpoint moments and ways to inspire and elevate teams. Attendees discover meaningful mentorships and insights into optimal job placement and professional pathways.

7:15

Continental Breakfast

7:50

Chairperson’s Recap

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

LUMINARY SHOWCASE Stay on the Pulse of Industry Innovations and Market Disruptors

8:00

Fireside Chat — Candid Conversation with an Industry Pioneer

William Roth
Founding Partner
Blue Fin Group

Bill Martin
Vice President, General Manager, Chief Commercial Officer
Accredo – An Express Scripts Company

8:45

PARTNERSHIP PAVILION Supply Chain Stakeholders Sound Off — Innovative Models Being Leveraged to Drive Product Pull Through and Patient Access

MODERATOR:

Clint Shadinger, PharmD, MBA
Strategic Clinical Program Manager, Trade Relations
Shields Health Solutions

CONVERSATION CONTRIBUTORS:

Jim Van Lieshout, MBA
Senior Director, Industry Relations and Contracting
Navitus Health Solutions

Ameet Wattamwars, Pharm. D.
Specialty Pharmacy Program Director
NYU Langone Health System

Stephen Samuel
CEO
Premier Pharmacy Services

9:30

How the New Wave of Algorithmic Care Will Disrupt Your Business

Zen Chu
Investor, PillPack;
Senior Lecturer in Healthcare Innovation,
MIT Sloan School of Management and Harvard-MIT Health Sciences & Technology

10:00

HHS KEYNOTE Healthcare Policy Address —
Current State of Regulatory Reform Driving Innovation and Access

Will Brady
Chief of Staff to the Deputy Secretary, Senior Advisor to the Secretary
Department of Health and Human Services (HHS)

10:30

Networking and Refreshment Break

11:00

CHOOSE FROM THREE TAILORED TRACKS (1-3)

1. Specialty Channel Network Design and Contracting

11:00

Creative Contracts —
Cutting-Edge Frameworks Tailored to the Needs of the Market

Donovan Quill
President & CEO
Optime Care Inc.

Tim Silcox
National Director, Trade and Reimbursement
MannKind Corporation

Charles Gayer
Chief Commercial Officer
Biocryst

11:40

Navigate Narrow Networks — Ensuring Patients Don’t Hit Roadblocks

Bob Raffo
President and CEO
FirstView

Tom Doyle
Senior Vice President, Strategy and Commercial Solutions
EVERSANA

Stuart Parker
Senior Director, Trade Relations
Mayne Pharma

12:20

Networking Luncheon

1:20

Assessment of Channel Partners and Determining Who Should Do What —
3PL? Distributor? Pharmacy?

Mark Polidoro
Director, Consulting Services
ValueCentric

2. Market Access, Patient Support and Hub Services Optimization

11:00

Key Considerations for Market Access Compliance

Jennifer Chillas
Senior Corporate Counsel, Law Department
Bristol-Myers Squibb

Michael Diaco
Assistant General Counsel
Pfizer

11:40

Striking the Right Balance —
A Look at the Level of Integration between Hub and Pharmacy

MODERATOR:

Snehal Patel
Vice President, Pharmacy and Access Solutions
Asembia

PANELISTS:

Allison Bridges
Senior Director, Access and Trade
kaléo

Paul Chen
Senior Director, Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

12:20

Networking Luncheon

1:20

Access and Affordability —
Zero-In on Coupons, Copays and Accumulator Programs

Daniel Lozano
Director of Operations
Rx Experts, Inc.

Stephen Hom, PharmD
Executive Vice President
Rx Experts, Inc.

3. Next-Gen Specialty Product Data Strategies

11:00

Optimization of Data Strategy and Alignment with the Business

Stephanie Levin
SBL Data Consulting, LLC

11:40

Getting Launch Ready in Rare Disease — Leveraging Machine Learning on Integrated Cross Channel Claims Data

Nitin Choudhary
Vice President, Consulting
IPM.ai

12:20

Networking Luncheon

2:00

Close of Conference